Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: CalculatedRisk who wrote (8608)	5/9/1998 9:28:00 PM
From: Ploni	Respond to of 18691

CNN just had a discussion on "Reliable Sources" blasting the NY Times for the cancer cure article. Basically they said things like: irresponsible reporting... What! The N.Y. Times only printed the article once. CNN spammed it over the entire weekend! They have a lot of nerve calling someone else irresponsible. ...information was not new... I found that out in 5 minutes by running a search on the Internet. CNN with its thousands of journalists couldn't figure that out before running the report over and over again? ... Watson incorrectly quoted, "false hope" for cancer patients (in the short term) and that it would take years to go from mice to men. Is it standard practice just to repeat someone else's reporting, without doing any checking on their own, BEFORE spamming it over and over again? They also mentioned the run up in ENMD. To which they contributed greatly. I never saw the original N.Y. Times article, and the reports I saw didn't mention the company. I ran an Internet search on the drug compounds mentioned, and identified ENMD. I thought that it might be a sleeper, and receive attention later, and was thinking of going long if it opened close to Friday's close ($12/share), but as it turned out, the company had been mentioned in the N.Y. Times article, and the stock gapped up like a rocket -- opening around $80/share. Of course, the great play would have been to put in a market short sell. This story was about two years old; I have no idea why it was re-run at this time. Perhaps someone at the N.Y. Times wanted to make a little money in the market.

To: CalculatedRisk who wrote (8608)	5/9/1998 10:03:00 PM
From: Joey Two-Cents	Read Replies (1) \| Respond to of 18691

<It was my understanding that shares are hard to find on ENMD. I'm considering a synthetic short.> I purchased some June 35 puts on ENMD. What amazes me is that everyone associated with this company and every article about this stock says the same thing that a cancer cure is years away and the current price of this stock is not justified. However, this stock is still up 200% for the week. I think once the short sellers and MM's and May options expire interest will wain and this stock will be back into the teens.